AGP Executive Report
Last update: 6 hours agoCancer Care: In a survey of cancer patients receiving radiation, 80% of cannabis users reported symptom relief and 89% said it improved their quality of life. The findings are self-reported, not proof of treatment effectiveness. Pain Research: New York approved a placebo-controlled trial of an oral THC solution for sciatica-related chronic pain, including checks on lasting benefit and safety. Patient Access: New Jersey’s governor signed reforms raising medical cannabis limits to three ounces monthly for 18 months, extending clinician authorizations to a year and removing limits for terminally ill and hospice patients. CBD Research: University of Regina researchers are studying cannabinoids, including CBD, for pain management after concussion. Safety: A new mouse study links cannabinoid exposure to anxiety-related brain activity; a separate inquest is examining whether prescribed cannabis may have affected a patient’s mental health, without establishing a cause. Industry Stakes: A looming federal restriction could upend the hemp-derived THC market, while state cannabis regulators say they still need federal guidance on rescheduling.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
